Designing libraries with CNS activity

Journal of Medicinal Chemistry

Volumn 42, Issue 24, 1999, Pages 4942-4951

  Ajay, ^a   Bemis, Guy W ^a   Murcko, Mark A ^a  

^a VERTEX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANOREXIGENIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; ANTIPARKINSON AGENT; ANTIVERTIGO AGENT; ANXIOLYTIC AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL STIMULANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC AGENT; NARCOTIC ANTAGONIST; NEUROLEPTIC AGENT; NEUROTROPIC AGENT; NOOTROPIC AGENT; SEDATIVE AGENT; SEROTONIN ANTAGONIST; SPASMOLYTIC AGENT; TRANQUILIZER;

ARTICLE; ARTIFICIAL NEURAL NETWORK; CENTRAL NERVOUS SYSTEM; CHEMICAL ANALYSIS; COMPUTER AIDED DESIGN; CONTROLLED STUDY; DRUG ACTIVITY; LIBRARY;

ANIMALS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM AGENTS; CHEMISTRY, PHYSICAL; COMBINATORIAL CHEMISTRY TECHNIQUES; DATABASES, FACTUAL; HYDROGEN BONDING; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; NITROGEN; STRUCTURE-ACTIVITY RELATIONSHIP; USER-COMPUTER INTERFACE;

EID: 0033518275     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990017w     Document Type: Article

References (34)

1. Johnson, M. A.; Maggiora., G. M. Concepts and applications of molecular similarity; Wiley: New York, 1990.
2. Ajay; Walters, W. P.; Murcko, M. A. Can we learn to distinguish between "Drug-like" and "Nondrug-like" molecules? J. Med. Chem. 1998, 41, 3314-3324.
3. Sadowski, J.; Kubinyi, H. A scoring scheme for discriminating between drugs and nondrugs. J. Med. Chem. 1998, 41, 3325-3329.
4. Comprehensive Medicinal Chemistry Release 94. 1 is available from MDL Information Systems Inc., San Leandro, CA 94577. An electronic database of vol. 6 of Comprehensive Medicinal Chemistry, Pergammon Press, 1990, contains drugs already in the market.
5. MACCS-II Drug Data Report is available from MDL Information Systems Inc., San Leandro, CA 94577. An electronic database version of the Prous Science Publishers journal Drug Data Report, extracted from issues starting mid-1988, contains biologically active compounds in the early stages of drug development.
6. Burton, P. S.; Conradi, R. A.; Ho, N. F.; Hilgers, A. R.; Borchardt, R. How structural features influence the biomembrane permeability of peptides. J. Pharm. Sci. 1996, 85, 1336-1340.
7. Conradi, R. A.; Hilgers, A. R.; Ho, N. F.; Burton, P. S. The influence of peptide structure on transport across caco-2 cells. Pharm. Res. 1991, 8, 1453-1460.
8. Abbott, N. J.; Romero, I. A. Transporting therapeutics acroos the blood-brain barrier. Mol. Med. Today 1996, March, 106-113.
9. Spector, R. Drug transport in the Central Nervous System: Role of carriers. Pharmacology 1990, 40, 1-7.
10. Pardridge, W. M. CNS drug design based on principles of bloodbrain barrier transport. J. Neurochem. 1998, 70, 1782-1792.
11. Lloyd, E. J.; Andrews, P. R. A common structural model for central nervous system drugs and their receptors. J. Med. Chem. 1986, 29, 453-462.
12. Levin, V. A. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 1980, 23, 682-684.
13. 2 receptor histamine antagonists. J. Med. Chem. 1988, 31, 656-671.
14. Seelig, A.; Gottschlich, R.; Dervent, R. M. A method to determine the ability of drugs to diffuse through the blood-brain barrier. PNAS 1994, 91, 68-72.
15. Abraham, M.; Chadha, H. S.; Mitchell, R. C. Hydrogen-bonding. Part 36. Determination of blood-brain distribution using octanol-water partition coefficient. Drug Des. Discovery 1995, 13, 123-131.
16. Calder, J. D.; Ganellin, C. R. Predicting the brain-penetrating capability of histaminergic compounds. Drug Des. Discovery 1994, 11, 259-268.
17. Lombardo, F.; Blake, J. F.; Curatolo, W. J. Computation of brainblood partitioning of organic solutes via free energy calculations. J. Med. Chem. 1996, 39, 4750-4755.
18. Norinder, U.; Sjöberg, P.; Österberg, T. Theoretical calculation and prediction of brain-blood partitioning of organic solutes using molsurf parametrization and pls statistics. J. Pharm. Sci. 1998, 87, 952-959.
19. van de Waterbeemd, H.; Camenisch, G.; Folkers, G.; Chretien, J.; Raevsky, O. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J. Drug Target. 1998, 6, 151-165.
20. Fischer, H.; Gottschlich, R.; Seelig, A. Blood-brain barrier permeation: molecular parameters governing passive diffusion. J. Membr. Biol. 1998, 165, 201-211.
21. Bemis, G. W.; Murcko, M. A. The properties of known drugs. 1. molecular frameworks. J. Med. Chem. 1996, 39, 2887-2893.
22. Ajay. Unpublished results.
23. Moriguchi, I.; Hirono, S.; Liu, Q.; Nakagome, I.; Matsushita, Y. Simple method of calculating octanol/water partition coefficient. Chem. Pharm. Bull. 1992, 40, 127-130.
24. Brown, R. D.; Martin, Y. C. Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection. J. Chem. Inf. Comput. Sci. 1996, 36, 572-584.
25. Neal, R. M. An improved acceptance procedure for the hybrid Monte Carlo algorithm. J. Comput. Phys. 1994, 111, 194-203.
26. Buntine, W. L.; Weigand, A. S. Bayesian back-propagation. Complex Systems 1991, 5, 603-643.
27. Tierney, L. Markov chains for exploring posterior distributions (with discussion). Ann. Stat. 1994, 22, 1701-1762.
28. Drug Facts and Comparisons; St. Louis, MO, 1996.
29. Physicians' Desk Reference; Medical Economics Co. Inc.: Oradell, NJ, 1990.
30. Lien, E. J. Structure-activity relationships and drug disposition. Annu. Rev. Pharmacol. Toxicol. 1981, 21, 31-61.
31. Walters, W. P.; Stahl, M. T.; Murcko, M. A. Virtual screening - an overview. Drug Discuss. Today 1998, 3, 160-178.
32. Ajay. On better generalization by combining 2 or more models - a quantitative structure activity relationship example using neural networks. Chem. Intell. Lab. Sys. 1994, 24, 19-30.
33. Pardridge, W. M.; Sakiyama, R.; Fierer, G. Blood-brain barrier transport and brain sequestration of propranolol and lidocaine. Am. J. Physiol. 1984, 247, R582-R588.
34. Skinner, J. E. Neurocardiology shows that the central, not peripheral, action of propranolol reduces mortality following acute coronary artery occlusion in the conscious pig. Integr. Physiol. Behav. Sci. 1991, 26, 85-97.